☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
humira
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
March 29, 2023
Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)
November 20, 2020
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
Insights+ Key Biosimilars Events of May 2020
June 5, 2020
Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases
May 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.